The Medicine Maker featured Advarra’s Daniel Eisenman’s in-depth reflection on how things are evolving in the world of cell and gene therapies in the first of a two-part series.
The Medicine Maker featured Advarra’s Daniel Eisenman’s in-depth reflection on how things are evolving in the world of cell and gene therapies in the first of a two-part series.